Posted On: 08/14/2014 12:04:00 PM
Post# of 189
GNSZ ~ GenSpera to Present at Rodman & Renshaw 16th Annual Global Investment Conference
[PR Newswire] - SAN ANTONIO, Aug. 14, 2014 /PRNewswire/ -- GenSpera, Inc. (GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces it will be presenting at the Rodman & Renshaw 16th Annual Global Investment Conference. The conference will be held September 8-10, 2014 at the New York Palace Hotel in New York. The conference is attended by public companies, institutional investors, sophisticated private investors and industry executives. The Company will discuss the significance of the recently announced HCC clinical trial update for G-202, its lead drug candidate, as well as provide a corporate overview.
read full: http://finance.yahoo.com/news/genspera-presen...00029.html
[PR Newswire] - SAN ANTONIO, Aug. 14, 2014 /PRNewswire/ -- GenSpera, Inc. (GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces it will be presenting at the Rodman & Renshaw 16th Annual Global Investment Conference. The conference will be held September 8-10, 2014 at the New York Palace Hotel in New York. The conference is attended by public companies, institutional investors, sophisticated private investors and industry executives. The Company will discuss the significance of the recently announced HCC clinical trial update for G-202, its lead drug candidate, as well as provide a corporate overview.
read full: http://finance.yahoo.com/news/genspera-presen...00029.html
(0)
(0)Scroll down for more posts ▼
